Galecto

Galecto is a clinical-stage biopharmaceutical company developing novel treatments for cancer and liver diseases.

3 documented relationships

Hover or select an entity to isolate its relationships. Link thickness reflects the documented amount.

Detailed register

Garrett WinslowEmploymentGalecto
Reported^{2Redefining care for people with blood disordersdamoratx.com}
Function or item indicated by the source: “General Counsel”.
GalectoOwnershipPharmAkea
Amount not specifiedReported^{3Board of Directors Archives - Triumvira Immunologics | Engineered T Cell Therapiestriumvira.com}
Role or object indicated by the source: “acquisition”.
Dr. Amy WechslerBoard seatGalecto
October 15, 2024Reported^{1Galecto Strengthens Board of Directors with Appointment of Dr. Amy Wechslerfinance.yahoo.com}
Function or item indicated by the source: “Board of Directors”.

Sources

1.
Galecto Strengthens Board of Directors with Appointment of Dr. Amy Wechsler
Web pagefinance.yahoo.com
View original ↑ Back to text
2.
Redefining care for people with blood disorders
Web pagedamoratx.com
View original ↑ Back to text
3.
Board of Directors Archives - Triumvira Immunologics | Engineered T Cell Therapies
Web pagetriumvira.com
View original ↑ Back to text